BSE Live
Dec 18, 15:40Prev. Close
1272.00
Open Price
1271.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 18, 15:40Prev. Close
1272.00
Open Price
1277.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1280.00 (223)
| Cash Flow of Dr Reddys Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2,775.80 | 1,700.70 | 697.00 | 1,544.50 | 1,580.00 | |
| Net CashFlow From Operating Activities | 1,839.20 | 2,762.10 | 1,538.60 | 1,015.90 | 2,798.20 | |
| Net Cash Used In Investing Activities | -1,689.20 | -550.90 | -1,179.90 | 1,442.50 | -1,961.10 | |
| Net Cash Used From Financing Activities | -224.10 | -2,223.10 | -304.40 | -2,581.80 | -693.70 | |
| Foreign Exchange Gains / Losses | 0.00 | 4.40 | -0.30 | -12.00 | -9.20 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -74.10 | -7.50 | 54.00 | -135.40 | 134.20 | |
| Cash And Cash Equivalents Begin of Year | 113.20 | 120.70 | 66.70 | 202.10 | 60.00 | |
| Cash And Cash Equivalents End Of Year | 39.10 | 113.20 | 120.70 | 66.70 | 194.20 |
15.12.2025
12.12.2025
25.11.2025
11.11.2025
28.10.2025
Dr Reddys Labs Consolidated September 2025 Net Sales at Rs 8,828.30 crore, up 9.83% Y-o-Y
28.10.2025
Dr Reddys Labs Standalone September 2025 Net Sales at Rs 4,618.60 crore, down 31.03% Y-o-Y
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
24.07.2025
Dr Reddys Labs Standalone June 2025 Net Sales at Rs 7,809.50 crore, up 33.7% Y-o-Y
22.01.2025
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth
12.07.2023
Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang
24.01.2023
Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues
27.10.2022
Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop in net profit on weak US biz